Contact Information
51 Locust Street Suite 1, Northampton, Massachusetts 1060, United States
Detailed Information
OnCall Healthy Living Program
-
Services:
- Pregnant/postpartum women
- Naloxone and overdose education
- Discharge Planning
- Aftercare/continuing care
- Outcome follow-up after discharge
- Private for-profit organization
- Smoking not permitted
- Female
- Male
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Alcohol Detoxification
- Opioids detoxification
- Medication routinely used during detoxification
- Outpatient detoxification
- Regular outpatient treatment
- Outpatient
- Outpatient methadone/buprenorphine or naltrexone treatment
- Detoxification
- Substance use treatment
- Prescribes naltrexone
- Buprenorphine maintenance
- Buprenorphine detoxification
- Maintenance service with medically supervised withdrawal after stabilization
- Prescribes buprenorphine
- Relapse prevention with naltrexone
- HIV or AIDS education, counseling, or support
- Individual counseling
- Hepatitis education, counseling, or support
- Substance use disorder education
- Smoking/vaping/tobacco cessation counseling
- Federal military insurance (e.g., TRICARE)
- Private health insurance
- Cash or self-payment
- Medicaid
- State-financed health insurance plan other than Medicaid
- Medicare
- Hepatitis B (HBV) vaccination
- Hepatitis A (HAV) vaccination
- Telemedicine/telehealth therapy
- Brief intervention
- Motivational interviewing
- Contingency management/motivational incentives
- Cognitive behavioral therapy
- Trauma-related counseling
- Substance use disorder counseling
- Relapse prevention
- Metabolic syndrome monitoring
- HIV testing
- Testing for Hepatitis B (HBV)
- STD testing
- TB screening
- Drug and alcohol oral fluid testing
- Testing for Hepatitis C (HCV)
- Drug or alcohol urine screening
- Drug Enforcement Agency (DEA)
- State Substance use treatment agency
- State department of health
- Acamprosate (CampralĀ®)
- Nicotine replacement
- Buprenorphine without naloxone
- Naltrexone (oral)
- Buprenorphine with naloxone
- Naltrexone (extended-release, injectable)
- Clonidine
- Buprenorphine (extended-release, injectable)
- Non-nicotine smoking/tobacco cessation
- Screening for substance use
- Comprehensive substance use assessment
- Screening for tobacco use
- Interim services for clients
- Complete medical history/physical exam
- No formal relationship with prescribing entity
- Sign language services for the deaf and hard of hearing
- This facility administers/prescribes medication for alcohol use disorder
- Vaping not permitted
- Adults
- Young Adults
Special Programs/Groups Offered
Transitional Services
Facility Operation (e.g., Private, Public)
Facility Smoking Policy
Gender Accepted
Opioid Medications used in Treatment
Detoxification (medical withdrawal) Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Type of Care
Type of Opioid Treatment
Education and Counseling Services
Payment/Insurance/Funding Accepted
Medical Services
Treatment Approaches
Testing
License/Certification/Accreditation
Pharmacotherapies
Assessment/Pre-treatment
External Source of Medications Used for Alcohol Use Disorder Treatment
Language Services
Type of Alcohol Use Disorder Treatment
Facility Vaping Policy
Age Groups Accepted
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm